References
- Ginzberg E. The monetarization of medical care. New Eng J. Med. 1984; 310: 1162–1165
- Gibson RM, Waldo DR, Levit KR. National health expenditures. 1982. Health Care Finance Rev. 1983; 5: 1–31
- Spivey BE. The relation between hospital management and medical staff under a prospective-payment system. New Eng J. Med. 1984; 310: 984–986
- Yarbro JW, Mortenson LE. The need for diagnosis - related group 471: protection for clinical research. JAMA 1985; 253: 684–685
- Kennedy D. Government policies and the cost of doing research. Science 1985; 227: 480–484
- Anderson G., Steinberg E. To buy or not to buy: Technology acquisition under prospective payment. New Eng J. Med. 1984; 311: 182–185
- Landgarten S. Will DRG's affect staff privileges?. DRG Data Base Newsletter 1985; 1: 5–10
- Young DW, Saltman RB. Preventive medicine for hospital costs. Harvard Bus. Rev. 1983; 126–133
- Davis CK. The impact of prospective payment on clinical research. JAMA 1985; 253: 686–687